FibroBiologics (FBLG) Preferred Shares (2022)
FibroBiologics' (FBLG) quarterly Preferred Shares came in at $2.5 million in Q4 2022.
Analysis
FibroBiologics (FBLG) Preferred Shares (2022) Analysis & Trends
FibroBiologics (FBLG) has reported Preferred Shares for 1 consecutive years, with $2.5 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Preferred Shares changed N/A year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2022 stood at $2.5 million (changed N/A YoY), and the FY2022 full-year result was $2.5 million, changed N/A from the prior year.
- Preferred Shares was little changed at $2.5 million in Q4 2022 per FBLG's latest filing.
- Across five years, Preferred Shares topped out at $2.5 million in Q4 2022 and bottomed at $2.5 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 2,000.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | - |
| 10 | FibroBiologics | 10.66 Mn | 10.66 Mn | - | - |